🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark A. Preston

Brigham and Women's Hospital

ORCID: 0000-0003-1010-8464

Also affiliated with Harvard University, Mass General Brigham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.842Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

British Journal of Urology(2024)10.1111/bju.16509
Top 24%
0.842DataRank
Top 24%27 citations

Ashish M. Kamat, Michael A. O’Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan +19 more

Papers

Driven by 10 papers — median percentile 76. Top paper: “Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer”.

Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancer

British Journal of Urology(2024)10.1111/bju.16509
Top 24%
0.842DataRank
Top 24%27 citations

Ashish M. Kamat, Michael A. O’Donnell, Drupad Annapureddy, Jeffrey Howard, Wei Shen Tan +19 more

A pilot study of [18F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy

European Journal of Nuclear Medicine and Molecular Imaging(2025)10.1007/s00259-025-07287-y
N/A
0.173DataRank · unranked
2 citations

Mofei Liu, Matthew Robertson, Arda Könik, Su Cheng, Martin Bakht +10 more

Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes

Acta Oncologica(2023)10.1080/0284186x.2023.2238883
N/A
0.104DataRank · unranked
1 citations

Rebecca E. Graff, Alejandro Sánchez, Toni K. Choueiri, Eunyoung Cho, Mark A. Preston +2 more

Prostate cancer screening in African American men: a review of the evidence

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad193
N/A
0DataRank · unranked
21 citations

Roman Johnson, Faith Morley, Mohamed Albrair, Barbra A. Dickerman, Roman Gulati +11 more

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

The Journal of Urology(2021)10.1097/ju.0000000000001698
N/A
0DataRank · unranked
381 citations

Michael A. Gorin, Steven P. Rowe, Peter R. Carroll, Frédéric Pouliot, Stephan Probst +12 more

Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer

The Journal of Urology(2024)10.1097/ju.0000000000003927
N/A
0DataRank · unranked
3 citations

Anna Plym, Jane B. Vaselkiv, Kathryn L. Penney, Mark A. Preston, Adam S. Kibel +3 more

A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study

Applied Clinical Informatics(2024)10.1055/s-0044-1780511
N/A
0DataRank · unranked
3 citations

Mark A. Preston, Andrew J. Vickers, Deepak Malhotra, Behfar Ehdaie, Michael J. Healey +2 more

Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool

Applied Clinical Informatics(2024)10.1055/s-0044-1782619
N/A
0DataRank · unranked
2 citations

Mark A. Preston, Andrew J. Vickers, Deepak Malhotra, Behfar Ehdaie, Michael Healey +2 more

5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1234
N/A
0DataRank · unranked
8 citations

Carl Ceraolo, Kathryn M. Wilson, Claire H. Pernar, Emily M. Rencsok, Konrad H. Stopsack +8 more

5-alpha reductase inhibitors (5-ARI) and prostate cancer mortality among men with regular access to screening and health care.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.39
N/A
0DataRank · unranked
0 citations

Claire H. Pernar, Emily M. Rencsok, Konrad H. Stopsack, Sydney Grob, Edward L. Giovannucci +5 more